Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down.

In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.

GEMMA Collins revealed she is slimming down faster than ever as she updated fans on her health journey. The TOWIE star, 44, has gone from a size 26 to a size 20 in just three-months since starting ...

The company behind the weight loss sensation that transformed bodies and bank accounts across America just showed its own CEO ...

The boss of the drugs giant behind Ozempic has quit after falling behind in the global race to develop weight-loss medication ...

Weight loss drugs have been pitted against each other in a first of its kind head-to-head trial. Mounjaro and Wegovy were put ...

Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual ...

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

Landmark research suggests the appetite-suppressing jabs which mimic a hormone that makes us feel full also significantly cut ...

Weight-loss jab Mounjaro helps people shed significantly more weight than rival Wegovy, new research suggests.

Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...

"The changes are made in light of the recent market challenges Novo Nordisk has been facing, and the development of the ...